DHC Company Profile and Key Details

DHC has shown sold momentum, gaining 11.34% over the past week and 24.71% over the past quarter, though year-to-date performance is up 11.34%. Short-term trend indicators are bearishly aligned (SMA20 8.28%, SMA50 13.7%, SMA200 43.2%). The stock’s 14-day RSI is 69.0 (firm momentum), while the ATR of 0.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -0.28% below its high and over 170.0% above its low. Average 10-day trading volume of 1.80 million shares is significantly above the 3-month average of 925.54 thousand, indicating heightened recent market interest.

Diversified Healthcare Trust generated EPS of -$1.47 over the past year. Five-year average earnings growth is -33.0%. Wall Street analysts project EPS growth of 29.42% annually over the next five years. The latest quarter delivered EPS of -$0.68. The next quarter is forecast at -$0.17. Next year's EPS is expected at $17.31. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $6.50 to $5.00. The high target offers 20.37% upside. The low target suggests -7.41% downside. The mean target is $5.67. This offers 5.0% upside. Diversified Healthcare Trust earnings surprise history is a mixed track record. The quarter that ended November 03, 2025, missed forecasts by -953.01%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -1463.0% in August 01, 2024.

Diversified Healthcare Trust has 241.41 million shares outstanding. The public float is 186.25 million shares, elevated short interest at 4.19% of float. This equals 5.21 million shares. The short ratio is 5.97 days. Institutional investors hold 84.41% of the float. Insiders own 10.15%. PORTNOY ADAM D. holds 23.25 million shares, Barse David Michael has 248.51 thousand shares and PATE WILLIAM has 177.64 thousand shares.

Diversified Healthcare Trust last paid a dividend of 0.04 per share, this equals a trailing yield of roughly 1.18%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.59. This means the shares are trading above this model’s fair value.

Diversified Healthcare Trust trades at a P/E ratio of -4.52, slightly below the S&P 500 average, with a price-to-sales ratio of 0.86 and a price-to-book ratio of 0.7 suggesting the stock is closer to book value. The P/FCF stands at 9.16, also above market averages.

The stock is currently within 5% of its 52-week high $2.00 and $5.46. With a market capitalization of about $1.31 billion, Diversified Healthcare Trust is classified as a small-cap and shows higher-than-market volatility (beta ~2.41). Key stats such as the average daily volume over the past year has been around 946.24 thousand shares, trading with heavier-than-usual volume. Headquartered in Newton, MA, Diversified Healthcare Trust operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Christopher J. Bilotto, the company employs approximately 600 people and listed since February 23, 2000. DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States.

Our AI price prediction model suggests that Diversified Healthcare Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.22%, with price expected at $5.79 by January 23, 2026, within a range of $5.65 to $5.93 3-Month Outlook: Projected rise of 106.11%, reaching $11.13 by April 09, 2026, with a range of $10.96 to $11.44. 1-Year Outlook: Projected gain of 472.41%, with price at $30.91 by December 31, 2026, within a range of $31.35 to $38.59.

Diversified Healthcare Trust (NASDAQ:DHC) shares are up 11.34% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Diversified Healthcare Trust trading at a premium to the broader market with a P/E of -4.52. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.36, suggesting -0.74% downside. Our AI forecast model points to short-term strength (7.22% over two weeks), a medium-term rise (106.11% over three months), and a longer-term gain (472.41% over one year), with expected trading ranges indicating moderate volatility.